NEW YORK, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Pet Cancer Therapeutics Market - By Route Of Administration (Parenteral, Oral, And Others), By Cancer Type (Melanoma, Mast Cell Cancer, Lymphoma, Mammary & Squamous Cell Cancer, And Others), By Species Type (Cats, Dogs, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.
“According to the latest research study, the global pet cancer therapeutics market size was valued at about USD 11 billion in 2022. The market is expected to grow at a CAGR of 7% and is anticipated to reach USD 15 billion by 2030.”
Get a Free Sample PDF of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/pet-cancer-therapeutics-market
(A free sample of this report is available upon request; please contact us for more information.)
Pet Cancer Therapeutics Market Overview:
Pet cancer therapeutics is a new anti-cancer medicine that has the capacity for reducing the negative impact of cancer tissues. In addition to this, pet cancer therapeutics encompasses combination therapy as well as monotherapy. Apparently, the current research activities mainly focus on the proliferation of new anti-cancer medicines for enhancing efficiency and minimizing treatment side effects.
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, Revenue Analysis, SWOT Analysis, Historic and Forecast Growth, Porter's 5 Forces Analysis
- Zion Market Research Methodology
Report Scope:
| Report Attribute | Report Details |
| Market Size in 2022 | USD 11 Billion |
| Market Forecast in 2030 | USD 15 Billion |
| Growth Rate | CAGR of 7% |
| Base Year | 2022 |
| Forecast Years | 2023- 2030 |
| Key Companies Covered | Karyopharm Therapeutics Inc., Zoetis, Oasmia Pharmaceuticals AB, Zenoaq, AB Science, Aratana Therapeutics Inc., Rhizen Pharmaceuticals SA, Morphogenesis Inc., Boehringer Ingelheim International GmbH, Regeneus Ltd., VetDC Inc., and others. |
| Segments Covered | By Route of Administration, By Cancer Type, By Species Type, and By Region |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Customization Scope | Avail customized purchase options to meet your exact research needs. |
Directly Purchase a Copy of the Report | Quick Delivery Available - https://www.zionmarketresearch.com/buynow/su/pet-cancer-therapeutics-market
Key Insights from Primary Research
- The global pet cancer therapeutics market is anticipated to grow rapidly over the forecast timeline owing to a rise in awareness about pet ailments along with a rise in a tendency towards spending on pet care as well as treatment of pets.
- In terms of route of administration, the oral segment is slated to register the highest CAGR over the analysis period.
- Based on the cancer type, the mast cell cancer segment is set to dominate the cancer type segment over the forecast period.
- Based on the species type, the dog segment is predicted to lead the species type segment over the forecast period.
- Region-wise, the Asia-Pacific pet cancer therapeutics industry is projected to register the fastest CAGR during the assessment timeline.
Pet Cancer Therapeutics Market: Growth Factors
- Rise in the occurrence of cancer in pets will proliferate the growth of the market across the globe
The expansion of the pet cancer therapeutics market over the forecast period will be fueled by the rising adoption of cats and dogs as companions across the globe. A rise in the incidence of pet cancer in developed nations will accelerate the expansion of the global market in the coming years. In addition, an increase in the companion population in nations such as the United States, the United Kingdom, and Germany will result in enormous market demand over the projected timeframe.
In addition, an increase in awareness of pet diseases and an increase in the propensity to spend on pet care and treatment will amplify the growth of the global market over the next few years.
Pet Cancer Therapeutics Market: Restraints
- Less availability of veterinary doctors can restrict the global industry expansion
Low availability of veterinary oncologists and adverse effects caused by cancer treatment for pets can impede the growth of the global pet cancer therapeutics market. High treatment costs can pose a significant barrier to the global expansion of the industry.
Browse the full “Pet Cancer Therapeutics Market - By Route Of Administration (Parenteral, Oral, And Others), By Cancer Type (Melanoma, Mast Cell Cancer, Lymphoma, Mammary & Squamous Cell Cancer, And Others), By Species Type (Cats, Dogs, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Emerging Trends, Demand, Historical Data, And Forecasts 2023 – 2030” Report at https://www.zionmarketresearch.com/report/pet-cancer-therapeutics-market
Pet Cancer Therapeutics Market: Segmentation
The global pet cancer therapeutics market is sectored into route of administration, cancer type, species type, and region.
In route of administration terms, the global pet cancer therapeutics market is segregated into parenteral, oral, and others segments. Furthermore, the oral segment, which amassed nearly 65% of the global market revenue in 2022, is expected to record the highest CAGR in the forecasting timeframe.
Based on the cancer type, the global pet cancer therapeutics industry is sectored into melanoma, mast cell cancer, lymphoma, mammary & squamous cell cancer, and others segments. Moreover, the mast cell cancer segment, which accumulated a huge share of the global industry in 2022, is slated to lead the global industry over the projected timespan.
Based on the species type, the global pet cancer therapeutics market is divided into cats, dogs, and others segments. Moreover, the dogs segment, which dominated the segment in 2022, is predicted to dominate the global market share in the upcoming years.
Regional Analysis:
- North American market is predicted to remain the top contender over the expected timeframe
The growth of the pet cancer therapeutics market in the North American sub-continent over the forecast timeline is due to the huge presence of reputed industry participants in countries like the U.S. Additionally, a large-scale product penetration as well as product innovation to effectively treat various kinds of pet cancers will elevate the market growth over the estimated timeline. Apart from this, a rise in spending on veterinary care of pets by pet owners and supportive government guidelines related to research on pet cancer in countries such as the U.S. will proliferate the regional market size.
Asia-Pacific pet cancer therapeutics industry is set to register the fastest CAGR in the next couple of years due to the presence of key players in the developing countries of the region.
Request For Customization on This Report as Per Your Requirements - https://www.zionmarketresearch.com/custom/4232
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Competitive Players:
The report contains qualitative and quantitative research on the global Pet Cancer Therapeutics market, as well as detailed insights and development strategies employed by the leading competitors.
Some of the main players in the global Pet Cancer Therapeutics market include;
- Karyopharm Therapeutics Inc.
- Zoetis
- Oasmia Pharmaceuticals AB
- Zenoaq
- AB Science
- Aratana Therapeutics Inc.
- Rhizen Pharmaceuticals SA
- Morphogenesis Inc.
- Boehringer Ingelheim International GmbH
- Regeneus Ltd.
- VetDC Inc
The global Pet Cancer Therapeutics market is segmented as follows:
By Route of Administration
- Parenteral
- Oral
- Others
By Cancer Type
- Melanoma
- Lymphoma
- Mammary & squamous cell cancer
- Mast cell cancer
- Others
By Species Type
- Cat
- Dog
- Others
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Southeast Asia
- The Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Request Free Brochure of the Global Pet Cancer Therapeutics Market @ https://www.zionmarketresearch.com/requestbrochure/pet-cancer-therapeutics-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Pet Cancer Therapeutics industry?
- What are the main driving factors propelling the Pet Cancer Therapeutics Market forward?
- What are the leading companies in the Pet Cancer Therapeutics Industry?
- What segments does the Pet Cancer Therapeutics Market cover?
- How can I receive a free copy of the Pet Cancer Therapeutics Market sample report and company profiles?
Key Offerings:
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market
Browse Other Related Research Reports from Zion Market Research
- Extracorporeal Membrane Oxygenation Market By Modality (Venoarterial (VA), Venovenous (VV) And Arteriovenous (AV)), By Application (Respiratory, Cardiac, And Extracorporeal Cardiopulmonary Resuscitation (ECPR)), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Emerging Trends, Demand, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/extracorporeal-membrane-oxygenation-market
- Etanercept Market By Drug Type (Enbrel, Benepali, And Others), By Application (Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/etanercept-market
- Facial Rejuvenation Market By Product Type (Botulinum Toxin, Dermal Fillers, Micro Abrasion Equipment, Chemical Peels, Topical Skin Care Products, And Skin Rejuvenation Devices), By End-User (Hospitals & Clinics, Dermatology Clinics, And Beauty Centers & Spas), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/facial-rejuvenation-market
- Electroencephalography Devices Market By Product (8-Channel EEG, 21-Channel EEG, 25-Channel EEG, 32-Channel EEG, 40-Channel EEG, Multi-Channel EEG), By Type (Standalone Devices And Portable Devices), End-Use (Hospitals, Diagnostic Centers, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/electroencephalography-devices-market
- Protein Characterization And Identification Market By Product & Services (Consumable, Instruments, Services), By Application (Clinical Diagnosis, Drug Discovery Development, And Other Applications), By End Use (Contract Research Organizations, Academic Research Institutes, Pharmaceuticals & Biotechnology Companies, And Others), And By Region -Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/protein-characterization-and-identification-market-size
- Venous Thromboembolism Treatment Market By Product (Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps Without Gradient, And Segmented Pneumatic Compression Pumps With Calibrated Gradient), By Disease Indication (Deep Venous Thrombosis And Pulmonary Embolism), And By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/venous-thromboembolism-treatment-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Rushikesh Dorge | Zion Market Research
USA: +1 3479038971 | +1 7187054574
USA/Canada Toll Free: 1 (855) 465-4651 | Newark: 1 (302) 444-0166
UK: +44 2032 894158
India: +91 7768 006 007 | +91 7768 006 008
Email: sales@zionmarketresearch.com | Web: https://www.zionmarketresearch.com/
Follow Us on - LinkedIn | Twitter | Facebook | Pinterest | YouTube
Also Read Our Blogs: https://zmrblog.com/
